All opinions and descriptions are based on preclinical research, publicly available information, and the company's published materials
On the scientific side, researchers continue to study the effects of GLP-1 receptor agonists on mood, behavior, and neurological pathways
Early research targeting GLP-1 with oral glucose showed that it resulted in greater increases in insulin release and decreases in glucagon secretion compared with intravenous glucose
Today, with mounting evidence supporting renal benefits of SGLT2 inhibitors and GLP1 receptor agonists, early intervention is the new standard for kidney protection diabetes
It should also be emphasised that data collected using improperly stored or mishandled Retatrutide may be unreliable
These are chronic medications, much like antihypertensives or metformin